Alaproclate

This classification denotes an antidepressant agent with the molecular formula C13H18ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C4R42570ZO, chemically known as 4-chlor-alpha,alpha-dimethylphenethyl (rs)-2-aminopropionat but generally known as alaproclate, which bears US NIH Compound Identifier 2081. Alaproclate comes in base and hydrochloride forms. European Medicines Agency schedules Alaproclate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05292MIG. The term ALAPROCLATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules alaproclate in its Anatomical Therapeutic Chemical (ATC) Classification. ALAPROCLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alaproclate under HS 29224995 and SITC 51465. As of Q4 2014, ALAPROCLATE remains the US FDA Preferred Term for this commodity. Alaproclate bears US NLM identifiers UMLS ID C0051086 and NCI Concept Code C72685. SMILES: Clc1ccc(CC(OC(=O)C(N)C)(C)C)cc1.